Anti-Human CD13 APC


The WM-15 monoclonal antibody specifically reacts with human CD13, 150-170 type II transmembrane ectoenzyme also named aminopeptidase N and gp150. It is expressed by granulocytes and monocytes, epithelial cells, and endothelial cells. CD13 plays a role in the terminal degradation of peptides, antigen processing, and chemokine cleavage, and cellular adhesion. LMI071

Clone
WM15
Format:
APC
Applications
FC
Reactivity
Human
Isotype:
Mouse IgG1, kappa
Research Interest:
Cell Type:
Preperation:
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
Formulation:
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
References:

Barclay, A. N., Brown, M. H., Law, S. A. K. A., McKnight, A. J., Tomlinson, M. G., & van der Merwe, P. A. (1997). The leucocyte antigen factsbook. Academic Press.

Look, A. T., Ashmun, R. A., Shapiro, L. H., & Peiper, S. C. (1989). Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. Journal of Clinical Investigation83(4), 1299.

Favaloro, E. J., Moraitis, N., Bradstock, K., & Koutts, J. (1990). Co‐expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis. British journal of haematology74(4), 385-394.

MED: 19047085

Related Post